GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » Total Assets

MBCOF (Marvel Biosciences) Total Assets : $0.36 Mil (As of Jul. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Marvel Biosciences Total Assets?

Marvel Biosciences's Total Assets for the quarter that ended in Jul. 2024 was $0.36 Mil.

During the past 12 months, Marvel Biosciences's average Total Assets Growth Rate was 26.10% per year. During the past 3 years, the average Total Assets Growth Rate was 24.60% per year.

During the past 5 years, Marvel Biosciences's highest 3-Year average Total Assets Growth Rate was 24.60%. The lowest was 17.40%. And the median was 21.00%.

Total Assets is connected with ROA %. Marvel Biosciences's annualized ROA % for the quarter that ended in Jul. 2024 was -564.71%. Total Assets is also linked to Revenue through Asset Turnover. Marvel Biosciences's Asset Turnover for the quarter that ended in Jul. 2024 was 0.00.

Marvel Biosciences Total Assets Historical Data

The historical data trend for Marvel Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Total Assets Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
Total Assets
0.22 1.97 0.71 0.51 0.36

Marvel Biosciences Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.32 0.53 0.25 0.36

Marvel Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Marvel Biosciences's Total Assets for the fiscal year that ended in Jul. 2024 is calculated as

Total Assets=Total Equity (A: Jul. 2024 )+Total Liabilities (A: Jul. 2024 )
=-2.061+2.419
=0.36

Marvel Biosciences's Total Assets for the quarter that ended in Jul. 2024 is calculated as

Total Assets=Total Equity (Q: Jul. 2024 )+Total Liabilities (Q: Jul. 2024 )
=-2.061+2.419
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences  (OTCPK:MBCOF) Total Assets Explanation

Total Assets is connected with ROA %.

Marvel Biosciences's annualized ROA % for the quarter that ended in Jul. 2024 is

ROA %=Net Income (Q: Jul. 2024 )/( (Total Assets (Q: Apr. 2024 )+Total Assets (Q: Jul. 2024 ))/ count )
=-1.728/( (0.254+0.358)/ 2 )
=-1.728/0.306
=-564.71 %

Note: The Net Income data used here is four times the quarterly (Jul. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Marvel Biosciences's Asset Turnover for the quarter that ended in Jul. 2024 is

Asset Turnover
=Revenue (Q: Jul. 2024 )/( (Total Assets (Q: Apr. 2024 )+Total Assets (Q: Jul. 2024 ))/ count )
=0/( (0.254+0.358)/ 2 )
=0/0.306
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Marvel Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » Total Assets
Comparable Companies
XCNQ:GLOW TSX:IPCI XCNQ:BRAX XCNQ:CMND XCNQ:BIOV XCNQ:NIRV TSXV:WAVE XCNQ:NOVA XCNQ:MBIO TSXV:SVS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
MRVL:Canada
Address
505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Website
https://www.marvelbiotechnology.com
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.